相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CD40 Agonist Antibodies in Cancer Immunotherapy
Robert H. Vonderheide
ANNUAL REVIEW OF MEDICINE, VOL 71, 2020 (2020)
Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy
Xu Lei et al.
CANCER LETTERS (2020)
Myeloid-derived suppressor cells-new and exciting players in lung cancer
Zhenzhen Yang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Human chimeric antigen receptor macrophages for cancer immunotherapy
Michael Klichinsky et al.
NATURE BIOTECHNOLOGY (2020)
Characterization of novel dual tandem CD19/BCMA chimeric antigen receptor T cells to potentially treat multiple myeloma
Liqing Kang et al.
BIOMARKER RESEARCH (2020)
Pluripotent stem cell-derived CAR-macrophage cells with antigen-dependent anti-cancer cell functions
Li Zhang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Long-term reprogramming of the innate immune system
Jorge Dominguez-Andres et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2019)
Targeting Programmed Cell Death-1 (PD-1) and Ligand (PD-L1): A new era in cancer active immunotherapy
Anastasia Constantinidou et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Membrane Cholesterol Efflux Drives Tumor-Associated Macrophage Reprogramming and Tumor Progression
Pieter Goossens et al.
CELL METABOLISM (2019)
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
James B. Wing et al.
IMMUNITY (2019)
Treg programming and therapeutic reprogramming in cancer
Mariela A. Moreno Ayala et al.
IMMUNOLOGY (2019)
CAR T-cell bioengineering: Single variable domain of heavy chain antibody targeted CARs
F. Rahbarizadeh et al.
ADVANCED DRUG DELIVERY REVIEWS (2019)
Synthetic T cell receptor-based lymphocytes for cancer therapy
Daniel Getts et al.
ADVANCED DRUG DELIVERY REVIEWS (2019)
Construction and validation of the CRISPR/dCas9-EZH2 system for targeted H3K27Me3 modification
Xutao Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?
Yoshihiro Ohue et al.
CANCER SCIENCE (2019)
Targeting the CBM complex causes Treg cells to prime tumours for immune checkpoint therapy
Mauro Di Pilato et al.
NATURE (2019)
CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity
Bryan D. Choi et al.
NATURE BIOTECHNOLOGY (2019)
Glioblastoma-Associated Microglia Reprogramming Is Mediated by Functional Transfer of Extracellular miR-21
Erik R. Abels et al.
CELL REPORTS (2019)
CD123 as a Therapeutic Target in the Treatment of Hematological Malignancies
Ugo Testa et al.
CANCERS (2019)
Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinoma
Bettina Langhans et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Hedgehog signaling promotes tumor-associated macrophage polarization to suppress intratumoral CD8+ T cell recruitment
Amy J. Petty et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Macrophage spatial heterogeneity in gastric cancer defined by multiplex immunohistochemistry
Yu-Kuan Huang et al.
NATURE COMMUNICATIONS (2019)
A combination of humanised anti-CD19 and anti-BCMA CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, phase 2 trial
Zhiling Yan et al.
LANCET HAEMATOLOGY (2019)
Cancer Stem Cells: The Architects of the Tumor Ecosystem
Briana C. Prager et al.
CELL STEM CELL (2019)
Metabolic rewiring of macrophages by CpG potentiates clearance of cancer cells and overcomes tumor-expressed CD47-mediated 'don't-eat-me' signal
Mingen Liu et al.
NATURE IMMUNOLOGY (2019)
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Stephen J. Schuster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
MDSC; the Most Important Cell You Have Never Heard Of
R. J. Tesi
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
CART cell therapy for prostate cancer: status and promise
Haiyuan Yu et al.
ONCOTARGETS AND THERAPY (2019)
Engineering universal cells that evade immune detection
Robert Lanza et al.
NATURE REVIEWS IMMUNOLOGY (2019)
CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy
Terry J. Fry et al.
NATURE MEDICINE (2018)
Targeting cancer stem cells by using chimeric antigen receptor-modified T cells: a potential and curable approach for cancer treatment
Yelei Guo et al.
PROTEIN & CELL (2018)
Phase I study of chimeric antigen receptor modified T cells in treating HER2-positive advanced biliary tract cancers and pancreatic cancers
Kaichao Feng et al.
PROTEIN & CELL (2018)
Cancer Immunotherapy Using CAR-T Cells: From the Research Bench to the Assembly Line
Diogo Gomes-Silva et al.
BIOTECHNOLOGY JOURNAL (2018)
Building a Safer and Faster CAR: Seatbelts, Airbags, and CRISPR (Reprinted from Biol Blood Marrow Transplant vol 24, pg 27-31, 2018)
Miguel-Angel Perales et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor
Alexander D. Barrow et al.
CELL (2018)
A Unidirectional Transition from Migratory to Perivascular Macrophage Is Required for Tumor Cell Intravasation
Esther N. Arwert et al.
CELL REPORTS (2018)
Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity
David Wang et al.
CELL REPORTS (2018)
Biomaterial-assisted targeted modulation of immune cells in cancer treatment
Hua Wang et al.
NATURE MATERIALS (2018)
Roles of the immune system in cancer: from tumor initiation to metastatic progression
Hugo Gonzalez et al.
GENES & DEVELOPMENT (2018)
Targeting macrophages: therapeutic approaches in cancer
Luca Cassetta et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Biochemical Aspects of PD-L1 Regulation in Cancer Immunotherapy
Jinfang Zhang et al.
TRENDS IN BIOCHEMICAL SCIENCES (2018)
Chimeric antigen receptor (CAR)-transduced natural killer cells in tumor immunotherapy
Yuan Hu et al.
ACTA PHARMACOLOGICA SINICA (2018)
The spectrum of T cell metabolism in health and disease
Glenn R. Bantug et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma
Xiaoguang Li et al.
GUT (2017)
Tricking the balance: NK cells in anti-cancer immunity
Jens Pahl et al.
IMMUNOBIOLOGY (2017)
Macrophage Polarization: Anti-Cancer Strategies to Target Tumor-Associated Macrophage in Breast Cancer
Muhammad Tariq et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancer
Chiara Berlato et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Cocktail treatment with EGFR-specific and CD133-specific chimeric antigen receptor-modified T cells in a patient with advanced cholangiocarcinoma
Kai-chao Feng et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Allogeneic CD19-CAR-T cell infusion after allogeneic hematopoietic stem cell transplantation in B cell malignancies
Jun Liu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Chimeric antigen receptor T cells: a novel therapy for solid tumors
Shengnan Yu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Engineering Natural Killer Cells for Cancer Immunotherapy
Katayoun Rezvani et al.
MOLECULAR THERAPY (2017)
Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages
Jennifer L. Guerriero et al.
NATURE (2017)
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
S. S. Neelapu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Inhibition of colony stimulating factor-1 receptor abrogates microenvironment-mediated therapeutic resistance in gliomas
D. Yan et al.
ONCOGENE (2017)
CCR8+FOXp3+ Treg cells as master drivers of immune regulation
Yiftah Barsheshet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
RNA editing with CRISPR-Cas13
David B. T. Cox et al.
SCIENCE (2017)
Combined OX40L and mTOR blockade controls effector T cell activation while preserving Treg reconstitution after transplant
Victor Tkachev et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
NK cell-based immunotherapy for cancer
Fang Fang et al.
SEMINARS IN IMMUNOLOGY (2017)
Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy
Michael A. Cannarile et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
The regulation of immune tolerance by FOXP3
Ling Lu et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Tumor-Infiltrating Lymphocyte Therapy and Neoantigens
Paul F. Robbins
CANCER JOURNAL (2017)
Targeting neoantigens to augment antitumour immunity
Mark Yarchoan et al.
NATURE REVIEWS CANCER (2017)
Targeting NK-cell checkpoints for cancer immunotherapy
Aura Muntasell et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
Chimaeric antigen receptor T-cell therapy for tumour immunotherapy
Huan-huan Sha et al.
BIOSCIENCE REPORTS (2017)
Continuously expanding CAR NK-92 cells display selective cytotoxicity against B-cell leukemia and lymphoma
Sarah Oelsner et al.
CYTOTHERAPY (2017)
Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting
Kiyoung Eun et al.
BMB REPORTS (2017)
The Principles of Engineering Immune Cells to Treat Cancer
Wendell A. Lim et al.
CELL (2017)
Elevated lactate dehydrogenase (LDH) can be a marker of immune suppression in cancer: Interplay between hematologic and solid neoplastic clones and their microenvironments
Jennifer Ding et al.
CANCER BIOMARKERS (2017)
Immunometabolism governs dendritic cell and macrophage function
Luke A. J. O'Neill et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma
Congcong Zhang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study
Nicholas Butowski et al.
NEURO-ONCOLOGY (2016)
Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors
Aurore Morello et al.
CANCER DISCOVERY (2016)
ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma
Congcong Zhang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Selection and expansion of natural killer cells for NK cell-based immunotherapy
Petra S. A. Becker et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Bifunctional αHER2/CD3 RNA-engineered CART-like human T cells specifically eliminate HER2+ gastric cancer
Feifei Luo et al.
CELL RESEARCH (2016)
Targeting regulatory T cells in tumors
Chang Liu et al.
FEBS JOURNAL (2016)
Targeting of Tumor-Associated Glycoforms of MUC1 with CAR T Cells
John Maher et al.
IMMUNITY (2016)
Mesothelin as a target for chimeric antigen receptor-modified T cells as anticancer therapy
Mark O'Hara et al.
IMMUNOTHERAPY (2016)
Regulatory T Cell Modulation by CBP/EP300 Bromodomain Inhibition
Srimoyee Ghosh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
CD19-CAR engineered NK-92 cells are sufficient to overcome NK cell resistance in B-cell malignancies
Annette Romanski et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2016)
Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial
Timothy M. Nywening et al.
LANCET ONCOLOGY (2016)
PI3Kγ is a molecular switch that controls immune suppression
Megan M. Kaneda et al.
NATURE (2016)
Suppression of microRNA activity amplifies IFN-γ-induced macrophage activation and promotes anti-tumour immunity
Caroline Baer et al.
NATURE CELL BIOLOGY (2016)
Immunometabolism of regulatory T cells
Ryan Newton et al.
NATURE IMMUNOLOGY (2016)
Foxp3 and Toll-like receptor signaling balance Treg cell anabolic metabolism for suppression
Valerie A. Gerriets et al.
NATURE IMMUNOLOGY (2016)
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Vinit Kumar et al.
TRENDS IN IMMUNOLOGY (2016)
Chimeric Antigen Receptor-Modified T Cells for Solid Tumors: Challenges and Prospects
Yelei Guo et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
Starved and Asphyxiated: How Can CD8+ T Cells within a Tumor Microenvironment Prevent Tumor Progression
Ying Zhang et al.
FRONTIERS IN IMMUNOLOGY (2016)
Biomaterials and emerging anticancer therapeutics: engineering the microenvironment
Luo Gu et al.
NATURE REVIEWS CANCER (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T
Rachel A. Burga et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Cord blood: a promising source of allogeneic natural killer cells for immunotherapy
Hila Shaim et al.
CYTOTHERAPY (2015)
High numbers of macrophages, especially M2-like (CD163-positive), correlate with hyaluronan accumulation and poor outcome in breast cancer
Satu Tiainen et al.
HISTOPATHOLOGY (2015)
Hydrogen Sulfide Promotes Tet1-and Tet2-Mediated Foxp3 Demethylation to Drive Regulatory T Cell Differentiation and Maintain Immune Homeostasis
Ruili Yang et al.
IMMUNITY (2015)
Essential Role of Lysophosphatidylcholine Acyltransferase 3 in the Induction of Macrophage Polarization in PMA-Treated U937 Cells
Kosuke Taniguchi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2015)
CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study
Philippe A. Cassier et al.
LANCET ONCOLOGY (2015)
Stable inhibitory activity of regulatory T cells requires the transcription factor Helios
Hye-Jung Kim et al.
SCIENCE (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
Immunological mechanisms of the antitumor effects of supplemental oxygenation
Stephen M. Hatfield et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Immune evasion in cancer: Mechanistic basis and therapeutic strategies
Dass S. Vinay et al.
SEMINARS IN CANCER BIOLOGY (2015)
Anticancer Cytokines: Biology and Clinical Effects of Interferon-α2, Interleukin (IL)-2, IL-15, IL-21, and IL-12
Theofanis Floros et al.
SEMINARS IN ONCOLOGY (2015)
Adaptive Immune Resistance: How Cancer Protects from Immune Attack
Antoni Ribas
CANCER DISCOVERY (2015)
Cancer stem cell targeted therapy: progress amid controversies
Tao Wang et al.
ONCOTARGET (2015)
Current concepts in the diagnosis and management of cytokine release syndrome
Daniel W. Lee et al.
BLOOD (2014)
Macrophage IL-10 Blocks CD8+ T Cell-Dependent Responses to Chemotherapy by Suppressing IL-12 Expression in Intratumoral Dendritic Cells
Brian Ruffell et al.
CANCER CELL (2014)
Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy
Carola H. Ries et al.
CANCER CELL (2014)
Antitumor activity and safety of combination therapy with the Toll-like receptor 9 agonist IMO-2055, erlotinib, and bevacizumab in advanced or metastatic non-small cell lung cancer patients who have progressed following chemotherapy
David A. Smith et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models
Yu Zhu et al.
CANCER RESEARCH (2014)
Tumor-Associated Macrophages: From Mechanisms to Therapy
Roy Noy et al.
IMMUNITY (2014)
Of CARs and TRUCKs: chimeric antigen receptor (CAR) T cells engineered with an inducible cytokine to modulate the tumor stroma
Markus Chmielewski et al.
IMMUNOLOGICAL REVIEWS (2014)
mTOR signaling, Tregs and immune modulation
Nicole M. Chapman et al.
IMMUNOTHERAPY (2014)
Effective Innate and Adaptive Antimelanoma Immunity through Localized TLR7/8 Activation
Manisha Singh et al.
JOURNAL OF IMMUNOLOGY (2014)
Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis
Laura Bonapace et al.
NATURE (2014)
Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
Oscar R. Colegio et al.
NATURE (2014)
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
Marco L. Davila et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity
Prasad S. Adusumilli et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Macrophage Regulation of Tumor Responses to Anticancer Therapies
Michele De Palma et al.
CANCER CELL (2013)
Effects of interleukin-18 on natural killer cells: costimulation of activation through Fc receptors for immunoglobulin
Shivani Srivastava et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Tumor Promotion by Intratumoral Plasmacytoid Dendritic Cells Is Reversed by TLR7 Ligand Treatment
Isabelle Le Mercier et al.
CANCER RESEARCH (2013)
An Inherently Bifunctional Subset of Foxp3+ T Helper Cells Is Controlled by the Transcription Factor Eos
Madhav D. Sharma et al.
IMMUNITY (2013)
An obligate cell-intrinsic function for CD28 in Tregs
Ruan Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Therapeutic opportunities for manipulating TReg cells in autoimmunity and cancer
Harald von Boehmer et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Epigenetic regulation of CD133/PROM1 expression in glioma stem cells by Sp1/myc and promoter methylation
G. Gopisetty et al.
ONCOGENE (2013)
Engineered SIRPα Variants as Immunotherapeutic Adjuvants to Anticancer Antibodies
Kipp Weiskopf et al.
SCIENCE (2013)
GITR Pathway Activation Abrogates Tumor Immune Suppression through Loss of Regulatory T-cell Lineage Stability
David A. Schaer et al.
CANCER IMMUNOLOGY RESEARCH (2013)
History of myeloid-derived suppressor cells
James E. Talmadge et al.
NATURE REVIEWS CANCER (2013)
Targeting the ERBB family in cancer: couples therapy
Niall Tebbutt et al.
NATURE REVIEWS CANCER (2013)
Immunotherapy of cancer in 2012
John M. Kirkwood et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Anti-IL-6 receptor mAb eliminates myeloid-derived suppressor cells and inhibits tumor growth by enhancing T-cell responses
Kentaro Sumida et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Neuropilin 1 deficiency on CD4+Foxp3+ regulatory T cells impairs mouse melanoma growth
Wiebke Hansen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Microglial Stimulation of Glioblastoma Invasion Involves Epidermal Growth Factor Receptor (EGFR) and Colony Stimulating Factor 1 Receptor (CSF-1R) Signaling
Salvatore J. Coniglio et al.
MOLECULAR MEDICINE (2012)
CD25 Blockade Depletes and Selectively Reprograms Regulatory T Cells in Concert with Immunotherapy in Cancer Patients
Andrew J. Rech et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Targeting natural killer cells and natural killer T cells in cancer
Eric Vivier et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Adoptive immunotherapy for cancer: harnessing the T cell response
Nicholas P. Restifo et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Expression of a Functional CCR2 Receptor Enhances Tumor Localization and Tumor Eradication by Retargeted Human T cells Expressing a Mesothelin-Specific Chimeric Antibody Receptor
Edmund K. Moon et al.
CLINICAL CANCER RESEARCH (2011)
Chimeric antigen receptor (CAR)-engineered lymphocytes for cancer therapy
Carlos A. Ramos et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2011)
Interleukin (IL)-2 and IL-15 have different effects on human natural killer lymphocytes
Anne-Helene Pillet et al.
HUMAN IMMUNOLOGY (2011)
Trafficking of CAR-Engineered Human T Cells Following Regional or Systemic Adoptive Transfer in SCID Beige Mice
Ana Caterina Parente-Pereira et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2011)
Nanotechnologies to use bisphosphonates as potent anticancer agents: the effects of zoledronic acid encapsulated into liposomes
Monica Marra et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2011)
Foxo Transcription Factors Control Regulatory T Cell Development and Function
Yann M. Kerdiles et al.
IMMUNITY (2010)
Enhanced Tumor Trafficking of GD2 Chimeric Antigen Receptor T Cells by Expression of the Chemokine Receptor CCR2b
John A. Craddock et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Targeted therapy in non-small-cell lung cancer-is it becoming a reality?
Filip Janku et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
The phenotypic and functional characteristics of umbilical cord blood and peripheral blood natural killer cells
Michael R. Verneris et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
Helena Harlin et al.
CANCER RESEARCH (2009)
A Distinct Macrophage Population Mediates Metastatic Breast Cancer Cell Extravasation, Establishment and Growth
Binzhi Qian et al.
PLOS ONE (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis
Li Yang et al.
CANCER CELL (2008)
Inhibition of bone and muscle metastases of lung cancer cells by a decrease in the number of monocytes/macrophages
Koji Hiraoka et al.
CANCER SCIENCE (2008)
Transforming growth factor-β receptor blockade augments the effectiveness of adoptive T-cell therapy of established solid cancers
Africa Wallace et al.
CLINICAL CANCER RESEARCH (2008)
Inducible reprogramming of human T cells into Treg cells by a conditionally active form of FOXP3
Sarah E. Allan et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Glucose uptake is limiting in T cell activation and requires CD28-mediated akt-dependent and independent pathways
Sarah R. Jacobs et al.
JOURNAL OF IMMUNOLOGY (2008)
Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens
Karim C. El Kasmi et al.
NATURE IMMUNOLOGY (2008)
Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function
Ping-Ying Pan et al.
BLOOD (2008)
Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo
Robert D. Loberg et al.
CANCER RESEARCH (2007)
Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft
Silvina Gazzaniga et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Epithelial inflammation is associated with CCL28 production and the recruitment of regulatory T cells expressing CCR10
Bertus Eksteen et al.
JOURNAL OF IMMUNOLOGY (2006)
Clinical experience with denileukin diftitox (ONTAK)
F Foss
SEMINARS IN ONCOLOGY (2006)
Mesothelin-family proteins and diagnosis of mesothelioma
BWS Robinson et al.
LANCET (2003)
An essential role for Scurfin in CD4+CD25+ T regulatory cells
R Khattri et al.
NATURE IMMUNOLOGY (2003)
分享论文
